Reveal LINQ vs Vivid T9/Vivid T8
AI Verdict
Choose Reveal LINQ if…
Choose Reveal LINQ if you need long-term, continuous, and discreet cardiac monitoring for patients experiencing infrequent or unexplained symptoms like syncope or suspected cryptogenic stroke. This implantable monitor is ideal for capturing elusive arrhythmias over an extended period, leveraging AI to reduce false alerts and provide accurate diagnostic data for up to three years.
View Reveal LINQ →Choose Vivid T9/Vivid T8 if…
Choose GE HealthCare Vivid T9/T8 if you require advanced, real-time cardiovascular ultrasound imaging with AI-powered tools for immediate diagnostic assessment and workflow efficiency. These systems are best suited for comprehensive cardiac and shared services imaging, providing automated measurements and enhanced visualization for a wide range of clinical scenarios in a hospital or clinic setting.
View Vivid T9/Vivid T8 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Reveal LINQ | Vivid T9/Vivid T8 |
|---|---|---|
| Deployment | The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs. | Unknown |
| FDA Status | Cleared AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Reveal LINQReveal LINQ offers high patient usability due to its minimally invasive, simplified insertion procedure and continuous, long-term monitoring for up to three years, allowing patients to largely 'set and forget' the device. Clinicians benefit from the Reveal LINQu2122 Mobile Manager app for convenient device management.
Clinical Value
Reveal LINQReveal LINQ provides significant clinical value through continuous ECG monitoring for up to three years, utilizing AccuRhythmu2122 AI algorithms to accurately detect cardiac arrhythmias and reduce false alerts. This long-term, passive monitoring is crucial for diagnosing infrequent symptoms like cryptogenic stroke and unexplained syncope.
Pricing & Value
Vivid T9/Vivid T8While both tools require contacting the vendor for specific pricing, GE HealthCare's Vivid T9/T8 provides a starting price for the Vivid T8 around $22,800, offering a degree of pricing transparency not found with Reveal LINQ. This initial cost indication gives Tool B a slight edge in pricing transparency.
Enterprise Readiness
Vivid T9/Vivid T8Both tools are FDA cleared and HIPAA compliant, demonstrating foundational enterprise readiness. However, the Vivid T9/T8 explicitly supports HIPAA compliance through features like disk encryption for patient data security and offers DICOM connectivity, which is a standard for seamless integration within imaging departments.
Innovation
Reveal LINQReveal LINQ stands out for its innovation as the world's smallest insertable cardiac monitor, providing continuous ECG monitoring for up to three years with AI-powered accuracy to reduce false alerts. This combination of miniaturization and long-duration, intelligent monitoring represents a distinct advancement in cardiac diagnostics.
Support & Docs
TieBoth Medtronic and GE HealthCare are major medical device manufacturers known for robust support and documentation. While specific comparative metrics are not available, both companies offer extensive manuals, technical guides, patient education materials, and dedicated support channels for their products.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Reveal LINQ | Vivid T9/Vivid T8 |
|---|---|---|
| Product Type | Tiny, implantable cardiac monitor | Advanced cardiovascular ultrasound systems |
| Company | Medtronic | GE HealthCare |
| Core AI Application | AccuRhythmu2122 AI algorithms for accurate detection and diagnosis of cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope, reducing false alerts. | AI-powered tools for enhanced imaging, workflow, and diagnostics, including Cardiac Auto Doppler, AutoEF, AFI, and AI Auto Measure (2D & Spectrum Recognition). |
| Primary Function | Continuous ECG monitoring for up to three years to detect and diagnose cardiac arrhythmias. | Advanced cardiovascular ultrasound imaging and diagnostics across various medical specialties. |
| Target Specialties | Cardiology, Neurology | Cardiology, Critical Care, Radiology |
| Device Form Factor / Key Hardware Aspect | World's smallest insertable cardiac monitor (1.2 mL), MRI Conditional (1.5T and 3T) with no post-insertion waiting. | Ergonomic design with continuously tiltable HD LCD monitor and multi-touch screen, DICOM connectivity for image and data management. |
Videos
Demos, reviews, and walkthroughs featuring Reveal LINQ and Vivid T9/Vivid T8.